Mark Cockett is the President and Chief Scientific Officer at Paratus Sciences, a company decoding evolution to develop new medicines. With over 30 years of experience, he has delivered numerous antiviral drugs to market, including atazanavir and entecavir. He holds a Ph.D. in molecular and cell biology from The Open University and is described by colleagues as a "great people leader" and one of the "smartest scientists" theyve worked with.
There is no publicly available information about his personal life or interests outside of his extensive professional career in the pharmaceutical and biotech industries. His work demonstrates a deep commitment to scientific discovery and addressing unmet medical needs through innovative research and development strategies.
He is leading research at Paratus Sciences that leverages the unique evolutionary traits of bats, such as their resistance to disease and cancer, to discover novel therapeutics for human diseases.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.